Distinguished in Wyburn-Mason Syndrome
Check Dr. Gary K. Steinberg's experience treating your condition:
About Dr. Gary K. Steinberg

Gary Steinberg is a Neurosurgery expert in Palo Alto, California. Steinberg has been practicing medicine for over 43 years and is rated as a Distinguished expert by MediFind in the treatment of Wyburn-Mason Syndrome. He is also highly rated in 31 other conditions, according to our data. His top areas of expertise are Moyamoya Disease, Arteriovenous Malformation, Stroke, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery. He is licensed to treat patients in California. Steinberg is currently accepting new patients.

His clinical research consists of co-authoring 282 peer reviewed articles and participating in 12 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Gary K. Steinberg it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
213 Quarry Rd, Palo Alto, CA 94304
Other Locations
300 Pasteur Dr, 3rd Floor, Stanford, CA 94305
730 Welch Rd, Palo Alto, CA 94304
751 S Bascom Ave, San Jose, CA 95128
Background & Education
Graduate Institution
Stanford University School Of Medicine, 1980
Neurological Surgery in CA
Hospital Affiliations
Good Samaritan Hospital
Stanford Hospital
Wilmington Hospital
Lucile Packard Childrens Hospital Stanford
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
A Phase 2, Single Arm Study of CG0070 Combined With Pembrolizumab in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Phase 1/2A Study of the Safety and Efficacy of Modified Stromal Cells (SB623) in Patients With Stable Ischemic Stroke
View 7 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors